INAF.JK
Price:
$126
Market Cap:
$390.51B
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-04-18
Stock Exchange
JKT
Ticker
INAF.JK
According to PT Indofarma Tbk’s latest financial reports and current stock price. The company's current ROE is 78.64%. This represents a change of 274.25% compared to the average of 21.01% of the last 4 quarters.
The mean historical ROE of PT Indofarma Tbk over the last ten years is -42.94%. The current 78.64% ROE has changed -283.14% with respect to the historical average. Over the past ten years (40 quarters), INAF.JK's ROE was at its highest in in the June 2023 quarter at 172.27%. The ROE was at its lowest in in the December 2022 quarter at -284.13%.
Average
-42.94%
Median
-1.50%
Minimum
-496.17%
Maximum
89.66%
Discovering the peaks and valleys of PT Indofarma Tbk ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.61%
Maximum Annual ROE = 89.66%
Minimum Annual Increase = -115425.09%
Minimum Annual ROE = -496.17%
Year | ROE | Change |
---|---|---|
2023 | 89.66% | -118.07% |
2022 | -496.17% | 6.61% |
2021 | -7.39% | -115425.09% |
2020 | 0.01% | -99.59% |
2019 | 1.58% | -123.92% |
2018 | -6.59% | -25.03% |
2017 | -8.79% | 191.49% |
2016 | -3.02% | -372.24% |
2015 | 1.11% | 462.46% |
2014 | 0.20% | -102.15% |
The current ROE of PT Indofarma Tbk (INAF.JK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-137.97%
5-year avg
-82.46%
10-year avg
-42.94%
PT Indofarma Tbk’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PT Indofarma Tbk using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PT Indofarma Tbk or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is PT Indofarma Tbk's ROE?
How is the ROE calculated for PT Indofarma Tbk (INAF.JK)?
What is the highest ROE for PT Indofarma Tbk (INAF.JK)?
What is the 3-year average ROE for PT Indofarma Tbk (INAF.JK)?
What is the 5-year average ROE for PT Indofarma Tbk (INAF.JK)?
How does the current ROE for PT Indofarma Tbk (INAF.JK) compare to its historical average?